Biosynthesis of cinchona alkaloids
Article Meta
Article Date = 18 March 2026
Article URL = https://www.nature.com/articles/s41586-026-10227-x
Article Image = https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41586-026-10227-x/MediaObjects/41586_2026_10227_Fig1_HTML.png
Summary
This Nature paper deciphers key steps and genes in the biosynthesis of cinchona alkaloids — the family that includes quinine and quinidine. Using a mix of classical feeding experiments, single-nucleus RNA-seq, comparative transcriptomics, proteomics and enzyme fractionation, the authors identified previously unknown on-pathway intermediates (corynantheol, cinchonium and cyclo-cinchonaminal) and the enzymes that convert them.
Key enzymatic discoveries include an O-malonyltransferase (MAT) that installs a malonyl group on corynantheol, a BAHD-family enzyme repurposed as a cyclase (MCC) that triggers demalonylative cyclisation to form the quaternary ammonium cinchonium, a 2-oxoglutarate-dependent dioxygenase (CiS) that produces the cyclised intermediate, an alcohol dehydrogenase (CiR) that reduces to cinchonamine, a cytochrome P450 (CiO) that expands the indole to the quinoline core, and a keto-reductase (KR4) that reduces the quinoline ketone to final alkaloids.
The authors reconstituted downstream steps in Nicotiana benthamiana, produced both methoxylated and non-methoxylated dihydroquinoline products and demonstrated directed biosynthesis of halogenated quinoline analogues. The work reveals a malonylation–cyclisation strategy and broadens known BAHD enzyme functions beyond simple acyl transfer.
Key Points
- Previously unknown on-pathway intermediates were isolated and validated: corynantheol (11), cinchonium (12) and cyclocinchonaminal (13).
- MAT (an O-malonyltransferase) malonylates corynantheol to give a transient malonylated intermediate (14) used for cyclisation.
- MCC, a BAHD-family enzyme with cyclase activity, performs a demalonylative intramolecular cyclisation to generate the quaternary ammonium cinchonium (12).
- CiS (a 2-oxoglutarate-dependent dioxygenase) and CiR (an alcohol dehydrogenase) convert cinchonium into downstream intermediates including cyclocinchonaminal and cinchonamine.
- CiO (a CYP71 P450) catalyses the indole-to-quinoline ring expansion producing the quinoline ketones cinchonidinone and cinchoninone; KR4 reduces these ketones to the alcohol alkaloids.
- Single-nucleus RNA-seq, cross-species transcriptomics and proteomics were combined to prioritise candidates, dramatically narrowing the search space for functional genes.
- The pathway (or parts of it) was successfully reconstituted in N. benthamiana, and halogenated tryptamine precursors were accepted, enabling production of non-natural analogues.
- BAHD enzymes show unexpected functional breadth: MAT retains transferase activity while MCC lost canonical acyltransferase function and instead catalyses cyclisation.
Why should I read this?
Short answer: because the paper finally fills long-standing gaps in how quinine-type molecules are made in nature. If you care about natural-product biosynthesis, drug leads or synthetic biology, this study gives you the genes, the intermediates and a plug‑and‑play demonstration in a plant host — all the bits you need to think about making these molecules (or new variants) biotechnologically. It’s clever, practical and opens real routes for engineering quinoline alkaloids.
Author style
Punchy: these authors don’t just map metabolites — they tie them to genes and show the chemistry. If you’re working in natural products, metabolic engineering or medicinal chemistry, this is high-value reading: the paper hands you characterised enzymes and a roadmap for producing and modifying cinchona alkaloids.